skip to main content
Language:
Search Limited to: Search Limited to: Resource type Show Results with: Show Results with: Search type Index

Exploring the extended role of the community pharmacist in improving blood pressure control among hypertensive patients in a developing setting

Journal of pharmaceutical policy and practice, 2017-12, Vol.10 (1), p.39-39, Article 39 [Peer Reviewed Journal]

COPYRIGHT 2017 BioMed Central Ltd. ;The Author(s). 2017 ;ISSN: 2052-3211 ;EISSN: 2052-3211 ;DOI: 10.1186/s40545-017-0127-5 ;PMID: 29299319

Full text available

Citations Cited by
  • Title:
    Exploring the extended role of the community pharmacist in improving blood pressure control among hypertensive patients in a developing setting
  • Author: Marfo, Afia Frimpomaa Asare ; Owusu-Daaku, Frances Thelma
  • Subjects: Analysis ; Blood pressure ; Developing countries ; Drugstores ; Hypertension ; Medical research ; Medicine, Experimental ; pharmaceutical care ; pharmacist ; Pharmacists ; Pharmacy
  • Is Part Of: Journal of pharmaceutical policy and practice, 2017-12, Vol.10 (1), p.39-39, Article 39
  • Description: In most developing countries including Ghana, there is scant literature on the involvement of the community pharmacist in the care of patients with chronic conditions such as hypertension and blood pressure control. The objective of the study was to evaluate the effect of a pharmaceutical care model on blood pressure control and adherence among hypertensive patients. This was a quasi experimental design and the primary outcome measure was a change in systolic and diastolic blood pressure. One hundred and eighty hypertensive patients were recruited for the study: 90 in the intervention group and 90 in the control group. The intervention, consisting of health education, adherence counselling and medicine use review; was offered monthly for six months. At baseline there was no significant difference in demographic and clinical characteristics between the intervention and control group. Pharmaceutical care issues identified among the intervention group during the 6 months period were non effectiveness of therapy (  = 23), experience of side effects (  = 20) and nonadherence to therapy (  = 40). The mean diastolic blood pressure difference between the intervention group and the control group was statistically significant (  = 0.001). The mean adherence difference between the two groups was also statistically significant at the end of the study. (p = 0.001). The pharmaceutical care intervention offered by the pharmacist led to the resolution of some pharmaceutical care issues, improvement in diastolic blood pressure and adherence among hypertensive patients. Guidelines and polices to streamline these services are needed if they are to be made available in community pharmacies in developing countries.
  • Publisher: England: BioMed Central Ltd
  • Language: English
  • Identifier: ISSN: 2052-3211
    EISSN: 2052-3211
    DOI: 10.1186/s40545-017-0127-5
    PMID: 29299319
  • Source: Open Access: DOAJ Directory of Open Access Journals
    Open Access: PubMed Central
    Geneva Foundation Free Medical Journals at publisher websites
    AUTh Library subscriptions: ProQuest Central
    SpringerOpen(OpenAccess)
    ROAD: Directory of Open Access Scholarly Resources

Searching Remote Databases, Please Wait